Clinical Pancreatology for Practising Gastroenterologists and Surgeons

20 20 Camilleri M, Malhi H, Acosta A. Gastrointestinal complications of obesity. Gastroenterology 2017; 152(7):1656–1670.

21 21 Dobszai D, Mάtrai, Erỡss B, et al. Body‐mass index correlates with severity and mortality in acute pancreatitis: a meta‐analysis. World J Gastroenterol 2019; 25:729–743.

22 22 Natu A, Stevens T, Kang L, et al. Visceral adiposity predicts severity of acute pancreatitis. Pancreas 2017; 46:776–781.

23 23 Choi JS, Yi S‐W, Park JW, et al. Body mass index and the risk of acute pancreatitis by etiology: a prospective analysis of Korean National Screening Cohort. J Gastroenterol Hepatol 2019; 34(3):603–611.

24 24 Molitch ME. Diabetes mellitus. In: Walker HK, Hall WD, Hurst JW (eds) Clinical Methods: The History, Physical and Laboratory Examinations, 3rd edn. Boston: Butterworths, 1990, chapter 136.

25 25 Albai O, Roman D, Frandes M, et al. Hyperglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus. Ther Clin Risk Manag 2017; 13:515–522.

26 26 Garg R, Rustagi T. Management of hypertriglyceridemia‐induced acute pancreatitis. BioMed Res Int 2018; 2018:4721357.

27 27 Yin G, Cang X, Yu G, et al. Different clinical presentations of hyperlipidemic acute pancreatitis: a prospective study. Pancreas 2015; 44:1105–1110.

28 28 Elkouly MA, Salazar MJ, Simons‐Linares R. Hypertriglyceridemia‐associated drug‐induced acute pancreatitis. Pancreas 2019; 48(1):22–35.

29 29 Pedersen SB, Langsted A, Nordestgaard BG. Non‐fasting mild‐to‐moderate hyperglyceridemia and risk of acute pancreatitis. JAMA Intern Med 2016; 176(12):1834–1842.

30 30 Vipperla K, Sommerville C, Furlan A et al. Clinical profile and natural course in a large cohort of patients with hypertriglyceridemia and pancreatitis. J Clin Gastroenterol 2017; 51:77–85.

31 31 Wang Q, Wang G, Qiu Z, et al. Elevated serum triglycerides in the prognostic assessment of acute pancreatitis. A systematic review and meta‐analysis of observational studies. J Clin Gastroenterol 2017; 51:586–593

32 32 Sue LY, Batech M, Yadav D, et al. Effect of serum triglycerides on clinical outcomes in acute pancreatitis: findings from a regional integrated health care system. Pancreas 2017; 46:874–879.

33 33 Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol 2015; 110:1497–1503.

34 34 Zafrir B, Saliba W, Jubran A, et al. Severe hypertriglyceridemia‐related pancreatitis: characteristics and predictors of recurrence. Pancreas 2019; 48:182–186.

35 35 Preiss D, Tikkanen, MJ, Welsh P. et al. Lipid‐modifying therapies and risk of pancreatitis. JAMA 2012; 308(8):804–811.

36 36 Raphael KL, Wellingham FF. Hereditary pancreatitis: current perspectives. Clin Exp Gastroenterol 2016; 9:197–207.

37 37 Jalaly NY, Moran RA, Fargahi F, et al. An evaluation of factors associated with pathogenic PRSS1, SPINK1, CTFR, and/or CTRC genetic variants in patients with idiopathic pancreatitis. Am J Gastroenterol 2017; 112:1320–1329.

38 38 Hasan A, Moscoso DI, Kastrinos F. The role of genetics in pancreatitis. Gastrointest Endosc Clin North Am 2018; 28:587–603.

39 39 Weiss FU, Hasselbarth N, Párniczky, et al. Common variants in the CLDN2‐MORC4 and PRSS1‐PRSS2 loci confer susceptibility to acute pancreatitis. Pancreatology 2018; 18:477–481.

40 40 Lindkvist B, Appelros S, Manjer J, et al. A prospective cohort study of smoking in acute pancreatitis. Pancreatology 2008; 8(1):63–70.

41 41 Talukdar R, Vege SS. Recent developments in acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7(11 Suppl):S3–S9.

42 42 Tenner S. Drug‐induced acute pancreatitis: does it exist? World J Gastroenterol 2014; 20(44):16529–16534.

43 43 Meczker A, Miko A, Gede N et al. Retrospective matched‐cohort analysis of acute pancreatitis induced by 5‐aminosalicylic acid‐derived drugs. Pancreas 2019; 48:488–495.

44 44 Munigala S, Kanwai F, Xian H, et al. Increased risk of pancreatic adenocarcinoma after acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:1143–1150.

45 45 Chung S‐D, Chen K‐Y, Xirasagar S, et al. More than 9‐times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population. Pancreas 2012; 41:142–146.

46 46 Diaz LI, Li Y, Barkin JS. Natural history of spontaneous rupture of a pancreatic pseudocyst into the peritoneal cavity and its minimal noninvasive management. Pancreas 2019; 48(4):e20–e21.

47 47 Kiriyama S, Gabata T, Takada T, et al. New diagnostic criteria of acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17:24–36.

48 48 Ismail OZ, Bhayana V. Lipase or amylase for the diagnosis of acute pancreatitis? Clin Biochem 2017; 50:1275–1280.

49 49 Working Group IAP/APA Pancreatitis Guidelines. IAP/APA evidence‐based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13(4 Suppl 2):e1–e15.

50 50 Tṻrkvatan A, Erden A, Tṻrkoglu et al. Imaging of acute pancreatitis and its complications. Part 1: Acute pancreatitis. Diagn Interv Imaging 2015; 96:151–163.

51 51 Jang JW, Kim M‐H, Oh D, et al. Factors and outcomes associated with pancreatic duct disruption in patients with acute necrotizing pancreatitis. Pancreatology 2016; 16:958–965.

52 52 Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375:1972–1981.

53 53 Di M‐Y, Liu H, Yang Z‐Yet al. Prediction models of mortality in acute pancreatitis in adults. Ann Intern Med 2016; 165:482–490.

54 54 Wu BU. Prognosis in acute pancreatitis. Can Med Assoc J 2011; 183:673–677.

55 55 Singh V, Wu B, Bollen T, et al. A prospective evaluation of the bedside Index Severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol 2009; 104:966–971.

56 56 Singh VK, Wu BU, Bollen TL et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009; 7:1247–1251.

57 57 Koutroumpakis E, Wu BU, Bakker OJ, et al. Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis: a post hoc analysis of three larger prospective databases. Am J Gastroenterol 2015; 110:1707–1716.

58 58 Forsmark CE, Yadav D. Predicting the prognosis of acute pancreatitis. Ann Intern Med 2016; 165(7):523–524.

59 59 Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis, 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102–111.

60 60 Singh VK, Bollen TL, Bechien U et al. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol 2011; 9:1098–1103.

61 61 Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology 2018; 154:1103–1139.

62 62 Sinha A, Vazquez NQ, Faghih M, et al. Early predictors of fluid sequestration in acute pancreatitis. A validation study. Pancreas 2016; 45:306–310.

63 63 De‐Madaria E, Banks PA, Moya‐Hoyo N. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12:997–1002.

64 64 Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol 2017; 112:797–803.

65 65 Warndorf MG, Kurtzman JT, Bartel MJ, et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroentrol Hepatol 2011; 9:705–709.